ask="0.9798"
ask_size="41000"
average_daily_volume="880218"
bid="0.9100"
bid_size="1100"
book_value="0.6060"
change="+0.0005"
change_from_200_day_moving_average="-1.0811"
change_from_50_day_moving_average="-0.0498"
change_from_52_week_high="-3.9794"
change_From_52_week_low="0.4505"
change_in_percent="+0.0526%"
close="0.9505"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.2370"
ebitda="-8.78M"
eps_estimate_current_year="-1.1200"
eps_estimate_next_quarter="-0.2500"
eps_estimate_next_year="-0.3200"
ex_dividend_date="N/A"
float_shares="7029000"
high="0.9652"
high_52_weeks="4.9299"
last_trade_date="3/2/2017"
last_trade_price="0.9505"
last_trade_size="1000"
last_trade_time="3:59pm"
low="0.9500"
low_52_weeks="0.5000"
market_capitalization="6.79M"
moving_average_200_day="2.0316"
moving_average_50_day="1.0003"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.3300"
open="0.9500"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-53.2144%"
percent_change_from_50_day_moving_average="-4.9776%"
percent_change_from_52_week_high="-80.7197%"
percent_change_from_52_week_low="+90.1000%"
previous_close="0.9500"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.5677"
price_per_sales="2.6538"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="0.8000"
stock_exchange="NCM"
symbol="OPXA"
volume="146235"
weeks_range_52="0.5000 - 4.9299"
